Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Patrick Messerschmitt

Hand Surgery Cincinnati, OH Medical Doctor

NPI 1740491273 CMS profile 261348

4355 Ferguson Dr, Cincinnati, OH 45245

Open in the dashboard

General payments

$58,322

67 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Patrick Messerschmitt of Cincinnati, OH is reported in the CMS Open Payments database as having received $58,322 across 67 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $76 3
2023 General $28 1
2022 General $19 1
2021 General $5,641 8
2020 General $14,025 5
2019 General $38,533 49

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Patrick Messerschmitt
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Patrick Messerschmitt were reported at $76. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Patrick Messerschmitt Hand Surgery median Middle half National median
2019 $38,533 $383 $106–$1,905 $163
2020 $14,025 $172 $51–$1,268 $114
2021 $5,641 $263 $71–$1,591 $132
2022 $19 $336 $87–$1,938 $149
2023 $28 $233 $81–$1,114 $160
2024 $0 $258 $88–$1,203 $164
2025 $76 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $57,782 60 payments
  2. Pharmaceutical Business Consultants Limited $400 1 payment
  3. Smith+Nephew, Inc. $37 1 payment
  4. Horizon Therapeutics plc $36 2 payments
  5. Medartis Inc. $34 1 payment
  6. Medtronic, Inc. $19 1 payment
  7. Merck Sharp & Dohme Corporation $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $55,250 23 payments
  2. Travel and Lodging $2,011 16 payments
  3. Food and Beverage $661 27 payments
  4. Honoraria $400 1 payment
Products named General payments · program years 2019–2025
  1. Affixus $36,143 25 payments
  2. Alps Elbow $35,084 19 payments
  3. Alps Hand $24,940 21 payments
  4. DVR Crosslock Plates/Screws/Pegs $20,437 19 payments
  5. Alps Prox Tib Plates $18,750 7 payments
  6. Trauma Product Portfolio $855 7 payments
  7. Biocue $113 3 payments
  8. Juggerknot $113 3 payments
  9. Taperloc $67 1 payment
  10. DVR Anatomic Plates/Screws/Pegs $59 1 payment
  11. Other $360 13 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

382

Median for Hand Surgery: 118

Drug cost

$2,053

Median for Hand Surgery: $615

Branded share of claims

62%

Median for Hand Surgery: 34.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 102 $596
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 81 $354
Methylprednisolone Generic 47 $285
Ondansetron Odt Ondansetron Brand 25 $234
Clindamycin Hcl Generic 16 $227
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 29 $119
Promethazine Hcl Generic 35 $106
Meloxicam Generic 22 $73
Tramadol Hcl Generic 25 $60

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,399 Part D prescribers listed as Hand Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 71 billing codes

Paid by Medicare

$116,280

Of which drugs: $1,682

Medicare patients

318

Average age 73

Services billed

1,585

186 women, 132 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 71%
Arthritis 65%
Diabetes 28%
Ischemic heart disease 23%
Depression 22%
Chronic kidney disease 16%
Cancer 16%
Osteoporosis 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 135 341 $1,682

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

67 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hand Surgery in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record